Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials
University of North Carolina at Chapel Hill · Columbia University · +11 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
597
total citations
- FWCI
- 56.66
- Percentile
- 100%
- References
- 32
Citations per year
Authors
24Topics & keywords
Topics
Keywords
- Cobicistat
- Elvitegravir
- Tenofovir alafenamide
- Emtricitabine
- Medicine
- Human immunodeficiency virus (HIV)
- Double blind
- Virology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.